Spanios Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Spanios General Information

Description

Operator of a cancer contract research organization intended to use patient-derived organoid model systems to help find a cure for rare cancers. The company offers patient-derived three-dimensional tumor models, utilizing proprietary technology to create stable biobank models that replicate host tumor environments, enabling pharmaceutical biotechnology companies to accelerate their quest for targeted therapeutic options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Houston, TX 77021
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 2450 Holcombe Boulevard
  • Houston, TX 77021
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spanios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC Completed Startup
2. Angel (individual) Completed Startup
1. Accelerator/Incubator 01-Jan-2018 Completed Startup
To view Spanios’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Spanios Patents

Spanios Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250123268-A1 Compositions and methods for accelerating development of cancer therapeutics Inactive 17-Oct-2023
WO-2025085577-A1 Compositions and methods for accelerating development of cancer therapeutics Inactive 17-Oct-2023

Spanios Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
DTN Ventures Venture Capital Minority
To view Spanios’s complete investors history, request access »

Spanios FAQs

  • When was Spanios founded?

    Spanios was founded in 2017.

  • Where is Spanios headquartered?

    Spanios is headquartered in Houston, TX.

  • What industry is Spanios in?

    Spanios’s primary industry is Laboratory Services (Healthcare).

  • Is Spanios a private or public company?

    Spanios is a Private company.

  • What is Spanios’s current revenue?

    The current revenue for Spanios is .

  • How much funding has Spanios raised over time?

    Spanios has raised $500K.

  • Who are Spanios’s investors?

    Johnson & Johnson Innovation - JLABS and DTN Ventures have invested in Spanios.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process